期刊文献+

万古霉素高谷浓度给药方案的研究 被引量:9

Dosage regimen of vancomycin based on high trough concentration
原文传递
导出
摘要 目的建立万古霉素谷浓度为10~20μg·mL-1的给药设计方案。方法 采用Matxke方法估算药物动力学参数,以目标谷浓度为10~20μg·mL-1,利用药物动力学参数设计给药方案,比较预测谷浓度与实际谷浓度的差别并计算AUC0~24/MIC。结果43例患者的预测谷浓度为(15.25±1.60)μg·mL-1,实际谷浓度为(14.47±2.46)μg·mL-1,预测谷浓度的ME为0.78μg·mL-1(95%CI:0.13~1.42),MAE为1.57μg·mL-1(95%CI:1.09~2.06),RMAE为2.21μg·mL-1(95%CI:1.41~2.79)。预测谷浓度与实际谷浓度具有相关性(P<0.001,r=0.535);43例患者中有41例(95.35%)患者的实际谷浓度在10~20μg·mL-1。患者实际日剂量明显高于说明书推荐剂量(P<0.001)。当MIC≤1μg·mL-1时,43例患者中有42例(97.67%)患者的AUC0~24/MIC均可>400。结论本研究建立的给药方案可以满足谷浓度为10~20μg·mL-1的要求。 Objective To establish vancomycin dosage design regimens based on trough concentrations of 10-20 μg · mL^-1. Methods Pharmacokinetic parameters were estimated by Matzke method. Vancomycin dosage regimens were designed according to pharmacokinetic parameters and target trough concentrations ranging 10-20μg · mL^-1. We compared the predicted trough concentrations with measured trough concentrations and calculated AUCo-24/MIC. Resuits Predicted trough concentrations and measured trough concentrations were (15.25 ± 1.60) μg · mL^-1 and (14.47±2.46)μg · mL^-1 respectively. ME, MAE and RMAE were 0.78 μg · mL^-1 (95%CI: 0.13-1. 42) , 1.57 μg · mL^-1 (95%CI: 1.09-2.06) and 2.21 μg · mL^-1(950/00CI: 1.41-2.79) respectively. There was correlation between predicted trough concentrations and measured trough concentrations (P〈0. 001, r = 0. 535). The trough concentration of 41 out of the 43 patients (95.35%) ranged 10-20μg · mL^-1. Actual daily doses were significantly higher than those recommended by manufacturer's instruction. In all the 43 patients, AUC0-24/MIC in 42 patients (97.67%) was above 400 when MIC≤1μg · mL^-1. Conclusion The established dosage regimens meet the requirement of trough concentration ranging 10-20μg · mL^-1.
出处 《中南药学》 CAS 2011年第11期811-814,共4页 Central South Pharmacy
关键词 万古霉素 高谷浓度 给药方案 vancomycin high trough concerntratiom dosage regimen
  • 相关文献

参考文献19

  • 1Burton ME, Gentle DL, Vasko MR. Evaluation of a Bayesian method for predicting vancomycin dosing [J]. DICP, 1989,23 (4): 294-300.
  • 2Sheiner LB, Beal SL. Some suggestions for measuring predictive performance [J]. J Pharmacokinet Biopharm, 1981, 9 (4): 503-512.
  • 3Matzke GR, McGory RW, Halstenson CE, et al. Pharmacokinetics of vaneomycin in patients with various degrees of renal function[J]. Antimicrob Agents Chemother, 1984, 25 (4): 433-437.
  • 4Gemmell CG, Edwards DI, Fraise AP, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK [J]. J Antimicrob Chemother, 2006, 57 (4): 589-608.
  • 5Sader HS, Becker HK, Moet GJ, et al. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vaneo myein MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008) [J]. Diagn Microbiol Infect Dis, 2010, 66 (3): 329-331.
  • 6Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vaneomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods [J]. Antimicrob Agents Chemother, 2003, 47 (10): 3040-3045.
  • 7李昕,李焕德,徐兵,张莉,张明香,刘丽华,何鑫.万古霉素治疗细菌性肺炎患者时血药谷浓度与肾毒性相关性研究[J].中南药学,2009,7(5):352-356. 被引量:22
  • 8Rodvold KA, Blum RA, Fischer JH, et al. Vancomycin pharmacokinetics in patients with various degrees of renal function [J]. Antimicrob Agents Chemother, 1988, 32 (6): 848-852.
  • 9Murphy JE, GiUespie DE, Bateman CV. Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters [J]. Am J Health Syst Pharm, 2006, 63 (23): 2365-2370.
  • 10Marques-Minana MR, Saadeddin A, Peris JE. Population pharmaeokinetic analysis of vaneomyein in neonates. A new proposal of initial dosage guideline [J]. Br J Clin Pharmacol, 2010, 70 (5): 713-720.

二级参考文献15

  • 1房德敏,冯鑫,陈迪,王巨存,戴滨.高效液相色谱法测定人血浆中万古霉素浓度[J].中国新药杂志,2005,14(5):596-598. 被引量:17
  • 2祝永明,涂厉标,王真.互为内标法测定去甲万古霉素与万古霉素的血药浓度[J].中国医院药学杂志,2005,25(12):1126-1128. 被引量:24
  • 3蒋硕民,戚双双,王增寿.高效液相色谱法测定人血浆中万古霉素浓度[J].中国医院药学杂志,2006,26(11):1364-1366. 被引量:15
  • 4卢岩,孙健,张静,谈恒山.340例万古霉素血药浓度监测及临床用药合理性分析[J].中国医院药学杂志,2007,27(5):649-651. 被引量:38
  • 5中华人民共和国药典临床用药须知2005年版.化学药和生物制品卷[M].2005:546-547.
  • 6Hu MW,Anne L,Forni T,et al.Measurement of vancomycin on renally impaired patient samples using an new high performance liquid chromatography method with vitaminB12 internal standard:comparison of high-performance liquid chromatography,emit,and fluorescence polarization immunoassay methods[J].Ther Drug Monit,1990,12(6):562-569.
  • 7LuksaJ,MarusicA.Rapid high performance liquid chromatgraphic determination of vancomycin in human plasma[J].J Chromatogr B Biomed Appl,1995,667(2):277-281.
  • 8Jesús Valle MJ,López FG,Navarro AS.Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study[J].J Pharm Biomed Anal,2008,48(3):835-839.
  • 9Montse Enrique,Encarna García-Montoya,Montserrat Mi?arro,et al.Application of an Experimental Design for the Optimization and Validation of a New HPLC Method for the Determination of Vancomycin in an Extemporaneous Ophthalmic Solution[J].J Chromatogr Sci,2008,46(9):828-834.
  • 10Polard E,Le Bouquin V,Le Corre P,Mallédant Y,et al.Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients[J].Ther Drug Monit,1999,21(3):395-403.

共引文献38

同被引文献100

引证文献9

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部